Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1950 participants
OBSERVATIONAL
2024-07-23
2027-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PULSE PVC Registry: Multicenter Study on Focal Pulsed Field Ablation for Premature Ventricular Contractions
NCT07003412
Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF
NCT04198701
PULSED AF Post-Approval Study
NCT06578104
A Registry Based Collaborative to Measure Efficiency, Effectiveness, and Safety of Farapulse PFA Technology for AF
NCT06335082
Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation
NCT05164107
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject has been diagnosed with atrial fibrillation (AF)
* Planned procedure using commercially available PulseSelect™ PFA System.
* Willing to comply with study requirements and give informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Cardiac Ablation Solutions
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Khaldoun Tarakji, MD
Role: STUDY_DIRECTOR
Medtronic CAS Chief Medical Officer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vancouver General Hospital
Vancouver, British Columbia, Canada
McGill University Health Centre (MUHC)
Montreal, Quebec, Canada
Fuwai Hospital Chinese Academy of Medical Sciences
Beijing, , China
The Second Affiliated Hospital of Harbin Medical University
Harbin, , China
Nanjing Drum Tower Hospital
Nanjing, , China
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Shanghai, , China
Wuhan Asia General Hospital
Wuhan, , China
Centre Hospitalier Universitaire de Grenoble - Site Nord
Grenoble, , France
Les Hôpitaux de Chartres - Hôpital Louis Pasteur
Le Coudray, , France
Hôpital Privé Jacques Cartier
Massy, , France
Clinique Pasteur
Toulouse, , France
Universitäts Klinikum Frankfurt - Goethe-Universität
Frankfurt, , Germany
Universitätsklinikum Heidelberg
Heidelberg, , Germany
St. Vincenz Krakenhaus Paderborn
Paderborn, , Germany
St. Vincenz-Krankenhaus Paderborn
Paderborn, , Germany
Bioclinic Athens
Athens, , Greece
IRCCS Ospedale Sacro Cuore Don Calabria
Negrar, Verona, Italy
Azienda Ospedaliera di Ancona
Ancona, , Italy
St Antonius Ziekenhuis
Nieuwegein, , Netherlands
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Seoul National University Hospital
Seoul, Seoul, South Korea
Samsung Medical Center
Seoul, , South Korea
Severance Hospital
Seoul, , South Korea
Hospital Universitario Reina Sofía
Córdoba, , Spain
H. Univ. Virgen de la Victoria - Malaga
Málaga, , Spain
Complejo Asistencial Universitario de Salamanca
Salamanca, , Spain
Basildon and Thurrock University Hospitals
Basildon, , United Kingdom
University Hospitals Coventry & Warwickshire
Coventry, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PulseSelect™ PFA Registry
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.